-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Initiates Coverage On BioNTech with Neutral Rating, Announces Price Target of $110

Benzinga·05/29/2025 13:42:56
Listen to the news
Goldman Sachs analyst Asad Haider initiates coverage on BioNTech (NASDAQ:BNTX) with a Neutral rating and announces Price Target of $110.